Alejandro Martínez Bueno
Alejandro Martínez Bueno
HEAD OF SERVICE
See more specialists on
Barcelonabarcelona
en/medical-staff/oncologist
Dr. Alejandro Martínez Bueno is a leading medical oncologist with a strong academic background, having earned his degree in Medicine and Surgery from the Universidad de Cantabria. He currently practices at the Hospital Universitario Dexeus, where he is a specialist in medical oncology . His contribution to the field of oncology is reflected in his most notable publication, "Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial," published in eClinicalMedicine in June 2025. Furthermore, Dr. Martínez Bueno is an active member of the Spanish Society of Medical Oncology , underscoring his commitment to the advancement of oncology in Spain.
Key information
- Latest Publication:Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
- Belongs to:GEICAM
Professional Details
Hospital Universitari Dexeus
HEAD OF SERVICE
January 2023
Hospital Gral. de L'Hospitalet
Medical Oncologist
December 2010
Hospital Gral. de L'Hospitalet
Staff Specialist
December 2010
Hospital Gral. de Granollers.
Medical Oncologist
June 2009
Hospital Gral. de Granollers.
Staff Specialist
June 2009
Hospital Universitario Cruces
Consultant
January 2004
Hospital Can Misses
Medical Oncologist
January 2003
Hospital Can Misses
Head of the Department of Medical Oncology
January 2003
Hospital Universitario Torrecardenas
Staff Specialist
November 2002
Hospital Universitario Donostia
Staff Specialist
June 2002
Hospital Universitario Donostia
Specialist doctor
January 2002
H. Txagorritxu
Medical Oncologist
January 2002
H. Granollers
Medical Oncologist
January 2002
Hospital Gral. de L'Hospitalet
Medical Oncologist
January 2002
Hospital Universitario Cruces
Medical Oncologist
January 2002
Hospital Can Misses
Medical Oncologist
January 2002
Study
Medicine
university, Universidad de Cantabria
1958
Study
Bachelor of Medicine and Surgery
university, Universidad de Cantabria
1997
Specialized Healthcare Training
Medical Oncology
hospital
Specialized Healthcare Training
Oncology Specialist
hospital
Specialized Healthcare Training
Specialist in Medical Oncology
Language
IELTS 7.5
Another qualification
Master's degree in immuno-oncology
university
Another qualification
Master's degree in clinical research design and analysis
university
Another qualification
Diploma in Traditional Chinese Medicine
Another qualification
Course on Hereditary Cancer
Clinical Trials since 2014
2014
Clinical Trials in Breast Cancer, Melanoma, Lung Cancer, Bladder Cancer, Ovarian Cancer, Multiple solid tumours. Phase I
2004
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
Nat Med
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Journal Article
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
Journal Article
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study.
Journal Article
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting.
Journal Article
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Journal Article
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer.
Journal Article
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial.
eClinicalMedicine
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions
Mol Oncol
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme
Eur J Cancer
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Journal Article
Trastuzumab Deruxtecan in Patients with Central Nervous System Involvement from HER2-Positive Breast Cancer: The DEBBRAH Trial.
Journal Article
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial
ESMO Open
GEICAM
Sociedad Española de Oncología Médica
Grupo Español de Cáncer de Ovario
Sociedad Europea de Oncología Médica
Colegio Oficial de Médicos de Barcelona
SEOM (Sociedad Española de Oncología Médica)
GEICO (Grupo Español de Cáncer de Ovario)
ESMO (Sociedad Europea de Oncología Médica)
Grupo de Investigación de Cáncer de Mama (GEICAM)
American Society of Clinical Oncology (ASCO)
Italian
Intermediate
Spanish
Native
Catalan
Intermediate
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Hospital Universitari Dexeus
Calle Sabino Arana, 5-19 - Planta 1
08028 Barcelona
Articles on
Browse the latest articles on Tu canal de salud.
¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.